Cargando…

Complement Pathways in Membranous Nephropathy: Complex and Multifactorial

Detalles Bibliográficos
Autores principales:	Brglez, Vesna, Boyer-Suavet, Sonia, Seitz-Polski, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7210742/ https://www.ncbi.nlm.nih.gov/pubmed/32406418 http://dx.doi.org/10.1016/j.ekir.2020.02.1033

Ejemplares similares

Analysis and Management of Rituximab Resistance in PLA2R1-Associated Membranous Nephropathy
por: Teisseyre, Maxime, et al.
Publicado: (2021)

Advances in the Management of Primary Membranous Nephropathy and Rituximab-Refractory Membranous Nephropathy
por: Teisseyre, Maxime, et al.
Publicado: (2022)

Personalized Medicine for PLA2R1-Related Membranous Nephropathy: A Multicenter Randomized Control Trial
por: Brglez, Vesna, et al.
Publicado: (2020)

Rituximab Immunomonitoring Predicts Remission in Membranous Nephropathy
por: Teisseyre, Maxime, et al.
Publicado: (2021)

Neutralizing Anti-Rituximab Antibodies and Relapse in Membranous Nephropathy Treated With Rituximab
por: Boyer-Suavet, Sonia, et al.
Publicado: (2020)

Th17-Immune Response in Patients With Membranous Nephropathy Is Associated With Thrombosis and Relapses
por: Cremoni, Marion, et al.
Publicado: (2020)

Anti-PLA2R1 Antibodies Containing Sera Induce In Vitro Cytotoxicity Mediated by Complement Activation
por: Lateb, Maël, et al.
Publicado: (2019)

Membranous Nephropathy After Exposure to Immune Checkpoint Inhibitors
por: Benyahia, Rayane, et al.
Publicado: (2023)

Humoral and Cellular Response of Frontline Health Care Workers Infected by SARS-CoV-2 in Nice, France: A Prospective Single-Center Cohort Study
por: Cremoni, Marion, et al.
Publicado: (2021)

Functional Exhaustion of Type I and II Interferons Production in Severe COVID-19 Patients
por: Ruetsch, Caroline, et al.
Publicado: (2021)

The classical pathway triggers pathogenic complement activation in membranous nephropathy
por: Seifert, Larissa, et al.
Publicado: (2023)

Kappa Free Light Chains, Soluble Interleukin-2 Receptor, and Interleukin-6 Help Explore Patients Presenting With Brain White Matter Hyperintensities
por: Levraut, Michael, et al.
Publicado: (2022)

Breakthrough infections due to SARS-CoV-2 Delta variant: relation to humoral and cellular vaccine responses
por: Buscot, Matthieu, et al.
Publicado: (2023)

Proteinuria as a Biomarker for COVID-19 Severity
por: Ouahmi, Hajar, et al.
Publicado: (2021)

Membranous Nephropathy: The Journey Continues …
por: Hoxha, Elion, et al.
Publicado: (2015)

Calcineurin Inhibitors in Membranous Nephropathy
por: Ponticelli, Claudio, et al.
Publicado: (2021)

Immune response to BNT162b2 SARS-CoV-2 vaccine in patients living with HIV: The COVIH-DAPT study
por: Manni, Sabrina, et al.
Publicado: (2023)

Both Humoral and Cellular Immune Responses to SARS-CoV-2 Are Essential to Prevent Infection: a Prospective Study in a Working Vaccinated Population from Southern France
por: Graça, Daisy, et al.
Publicado: (2023)

Alternative Pathway Dysregulation and the Conundrum of Complement Activation by IgG4 Immune Complexes in Membranous Nephropathy
por: Borza, Dorin-Bogdan
Publicado: (2016)

Untargeted plasma metabolomic fingerprinting highlights several biomarkers for the diagnosis and prognosis of coronavirus disease 19
por: Occelli, Céline, et al.
Publicado: (2022)

Anti-phospholipase A2 receptor antibody levels at diagnosis predicts spontaneous remission of idiopathic membranous nephropathy
por: Jullien, Perrine, et al.
Publicado: (2017)

Blockage of the lysosome-dependent autophagic pathway contributes to complement membrane attack complex-induced podocyte injury in idiopathic membranous nephropathy
por: Liu, Wei Jing, et al.
Publicado: (2017)

Proteomic Analysis of Complement Proteins in Membranous Nephropathy
por: Ravindran, Aishwarya, et al.
Publicado: (2020)

Commentary: A retrospective multifactorial analysis of Pythium keratitis and review of the literature
por: Anitha, Venugopal, et al.
Publicado: (2021)

“Precision” Medicine in Membranous Nephropathy: Serology-Guided Therapy
por: Glassock, Richard J., et al.
Publicado: (2023)

Predicting Diabetic Nephropathy Using a Multifactorial Genetic Model
por: Blech, Ilana, et al.
Publicado: (2011)

Impact of Isolation Time of COVID-19 Patients in Intensive Care Unit on Healthcare Workers Contamination and Nursing Care Intensity
por: Doyen, Denis, et al.
Publicado: (2022)

Air pollution exposure induces a decrease in type II interferon response: A paired cohort study
por: Allouche, Jonathan, et al.
Publicado: (2022)

Alternative Pathway Is Essential for Glomerular Complement Activation and Proteinuria in a Mouse Model of Membranous Nephropathy
por: Luo, Wentian, et al.
Publicado: (2018)

Establishing a Case for Anti-complement Therapy in Membranous Nephropathy
por: Ayoub, Isabelle, et al.
Publicado: (2020)

Complement activation products in the circulation and urine of primary membranous nephropathy
por: Zhang, Mu-fan, et al.
Publicado: (2019)

Humoral and cellular responses after a third dose of SARS-CoV-2 BNT162b2 vaccine in patients with lymphoid malignancies
por: Re, Daniel, et al.
Publicado: (2022)

What Can Mercury Teach Us About Membranous Nephropathy and Minimal Change Disease?
por: Caza, Tiffany N., et al.
Publicado: (2022)

The Complex and Multifactorial Nature of Alzheimer’s Disease
por: Alkadhi, Karim, et al.
Publicado: (2011)

Complement induces podocyte pyroptosis in membranous nephropathy by mediating mitochondrial dysfunction
por: Wang, Hui, et al.
Publicado: (2022)

Breaking the Barrier–Glomerular C5b-9 as a Prognostic Marker in Membranous Nephropathy
por: Trinidad, Carlo Nemesio B., et al.
Publicado: (2022)

Can Urinary Complement Proteins Stratify Patients to Therapeutic Complement Inhibitors?
por: Medjeral-Thomas, Nicholas R.
Publicado: (2022)

Cholesterol Accumulation in Podocytes: A Potential Novel Targetable Pathway in Diabetic Nephropathy
por: Tufro, Alda
Publicado: (2013)

Baseline and early functional immune response is associated with subsequent clinical outcomes of PD-1 inhibition therapy in metastatic melanoma patients
por: Gérard, Alexandre, et al.
Publicado: (2021)

Dissecting the relationships of IgG subclasses and complements in membranous lupus nephritis and idiopathic membranous nephropathy
por: Na, Woong, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_lu10ctfkf9potl3vqiipfup9ld